ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KALV KalVista Pharmaceuticals Inc

7.52
0.00 (0.00%)
14 Jan 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jan 2023Apr 2023Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -26.95M-31.73M-29.09M-29.75M-33.15M-48.46M-44.22M-45.81M
Pre Tax Income -21.3M-26.31M-25.32M-27.65M-29.03M-44.65M-40.44M-42.27M
Net Income -21.3M-26.31M-25.32M-27.65M-29.03M-44.65M-40.44M-42.27M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -22.63M-27.3M-26.7M-27.13M-30.83M-47.35M-42.65M-43.69M
EBITDA -26.75M-31.54M-28.9M-29.55M-32.94M-48.24M-43.99M-45.58M
Year End 30 April 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.5M8.39M16.13M12.69M0000
Operating Income -22.34M-18.71M-29.82M-40.53M-57.92M-96.61M-110.87M-140.45M
Pre Tax Income -18.6M-15.81M-20.69M-29.24M-46.24M-82.34M-92.91M-126.64M
Net Income -18.6M-15.81M-20.82M-29.12M-46.24M-82.34M-92.91M-126.64M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.911-0.735-0.744-1.02-1.316-2.335-2.072-2.394
EBIT -20.01M-14.31M-22.14M-30.7M-48.19M-81.29M-95.09M-132M
EBITDA -22.3M-18.53M-29.44M-40.02M-57.39M-96.05M-110.15M-139.63M